CircuLite (Saddlebrook, New Jersey) reported that it has received conditional approval from the FDA of an IDE for its lead product, the Synergy Circulatory Support System, a minimally-invasive device designed to reverse the symptoms of heart failure in ambulatory chronic heart failure patients. Read More
